Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00774176 · ClinicalTrials.gov registry record

Pennsylvania Study Of Chronic Obstructive Pulmonary Exacerbations

A clinical trial, sponsored by Temple University.

Completed
Registry status
1,066
Enrollment target

NCT00774176 is a clinical trial that has completed, run by Temple University. The registered enrollment target is 1,066 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00774176 has completed, sponsored by Temple University.

COMPLETED
Registry status
1,066 participants
Enrollment target

Study Summary

The overall purpose of PA-SCOPE is to determine why black and rural residents of Pennsylvania might be at higher risk for deadly, debilitating, and costly hospitalizations for chronic obstructive pulmonary disease (COPD)- and then to show that repeat acute exacerbations in high-risk patients can be reduced with one simple intervention. We believe that 1) COPD patients who are black or who live in rural areas of Pennsylvania are at higher risk of acute exacerbations requiring hospitalization and 2) this elevated risk can be reduced with one simple intervention: access to a 1-800 Temple Call Center where patients can get immediate customized advice on managing COPD exacerbations in their early stages. We will test these beliefs in PA-SCOPE. The collaborators with Temple University Hospital on the PA-SCOPE project are Lancaster General Hospital, Western Pennsylvania Hospital, and the Philadelphia College of Osteopathic Medicine.

Trial Details

FieldValue
Enrollment Target 1,066 participants
Start Date 2004-06
Est. Completion 2008-05

Sponsor

Temple University

163 total trials

What the Registry Record Tells You About NCT00774176

The ClinicalTrials.gov registry entry for NCT00774176 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,066 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Temple University, which has 163 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00774176 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00774176 about?

NCT00774176 is a clinical study titled "Pennsylvania Study Of Chronic Obstructive Pulmonary Exacerbations". The overall purpose of PA-SCOPE is to determine why black and rural residents of Pennsylvania might be at higher risk for deadly, debilitating, and costly hospitalizations for chronic obstructive pulmonary disease (COPD)- and then to show that repeat acute exacerbations in high-risk patients can be ...

What is the current status of trial NCT00774176?

This trial is currently completed. The enrollment target is 1,066 participants. The study started on 2004-06. Estimated completion is 2008-05.

Who is sponsoring clinical trial NCT00774176?

This trial is sponsored by Temple University, which has 163 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.